Deprizac

Main information

  • Trade name:
  • Deprizac 20mg Capsule
  • Dosage:
  • 20mg
  • Pharmaceutical form:
  • Capsule
  • Units in package:
  • Blister pack of 10's (box of 30's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Intas Pharmaceuticals Limited

Documents

Localization

  • Available in:
  • Deprizac 20mg Capsule
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-7232
  • Authorization date:
  • 02-07-2022
  • Last update:
  • 06-04-2018